Teriparatide 0.25 Mg Injection 0.25 mg/ ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.25 mg/ ml
Reference Brands: Terrosa (EU)
Category: Osteoporosis
It is used to treat bone loss (osteoporosis) in men and postmenopausal women at high risk of fracture. It is a synthetic form of the parathyroid hormone naturally produced in the body. This Injection is the only drug that works on bone formation, while the other drugs work on bone resorption.
Product Description:
Used in the treatment of bone loss (osteoporosis) in men and postmenopausal women.
Teriparatide is a medication used in the treatment and management of osteoporosis, belonging to the anabolic class of osteoporosis therapies. It is a recombinant form of the first 34 amino acids of human parathyroid hormone (PTH) and functions as a potent osteoanabolic agent. Unlike continuous high levels of PTH, which can lead to bone resorption, intermittent low-dose administration of teriparatide stimulates bone formation more than resorption, increasing bone density and strength.
Teriparatide 0.25 Mg Injection — third party manufacturing & bulk supply
Teriparatide 0.25 Mg Injection 0.25 mg/ ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Teriparatide 0.25 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Teriparatide 0.25 Mg Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Teriparatide is used to treat osteoporosis in patients at high risk of fractures by stimulating new bone growth and increasing bone density.
Teriparatide is a recombinant peptide, the first 34 amino acids of human parathyroid hormone (PTH 1-34), produced using recombinant DNA technology.
The main trade names are Forteo (USA) and Forsteo (EU/UK).
Teriparatide is manufactured by Eli Lilly and Company.
The generic name is teriparatide.
Brand names are Forteo (USA), Terrosa (EU) and Forsteo (EU/UK).
Teriparatide injections are manufactured in GMP-certified facilities by Eli Lilly in the USA and distributed internationally under regional brand names.
Related Products
Abaloparatide
Strength:
80 mcg
Form: injection (prefilled syringe)
Reference Brands: Tymlos (USA), Eladynos (EU)
View Details
Pamidronate Disodium
Strength:
15 mg, 30 mg, 60 mg, 90 mg
Form: Injection
Reference Brands: Aredia (USA/EU)
View Details
Calcitonin Salmon
Strength:
100 IU/mL, 200 IU/mL
Form: Injection / nasal spray
Reference Brands: Fortical (USA), Miacalcin (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
